EUVIMEDEUVIMED entdecken
Crossref

TRIM3 modulates cisplmatin-resistant of cervical squamous cell carcinoma via endoplasmic reticulum stress signaling in vitro

Meiya Mao, Tianzi You, Kejun Xu, Huiqing Ding iD

Biochemistry and Cell Biology · 2025

DOI: 10.1139/bcb-2024-0154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2025. Verfasst von Meiya Mao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, PR China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Endoplasmic Reticulum Stress, Drug Resistance, Neoplasm, Cisplatin. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TRIM3 is widely recognized as a tumor suppressor gene. However, its precise role in cervical squamous cell carcinoma (CESC) remains elusive. Here, we observed a significant decrease in the expression of TRIM3 in CESC cells. Overexpression of TRIM3 suppresses cell proliferation and clonal formation. Through the establishment of cisplatin (cDDP)-resistant CESC cell lines, we discovered that the expression of TRIM3 was further downregulated in cDDP-resistant cells, while overexpression of TRIM3 enhanced cellular sensitivity to cDDP. Mechanistic investigations revealed that TRIM3 directly interacts with GRP78, a crucial protein involved in endoplasmic reticulum stress (ERS) pathway, promoting its ubiquitination degradation. Under cDDP treatment, the overexpression of TRIM3 in cDDP-resistant cells suppressed cell proliferation and downregulated the expression of drug-resistant genes, while simultaneously enhancing the activation of apoptosis signaling pathways. However, co-expression of TRIM3 and GRP78 restored cellular sensitivity to cDDP back to normal levels. Consequently, overexpressing TRIM3 in drug-resistant cells facilitates PERK activation and subsequent induction of apoptosis through inhibition of GRP78, ultimately suppressing drug resistance and inducing apoptosis in CESC cells. In conclution, our study suggests that the TRIM3/GRP78 axis regulates cDDP resistance in CESC cells by modulating the downstream apoptotic pathway of ERS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsEndoplasmic Reticulum StressDrug Resistance, NeoplasmCisplatinSignal TransductionCarcinoma, Squamous CellTripartite Motif ProteinsCarrier ProteinsHumansEndoplasmic Reticulum Chaperone BiPFemaleHeat-Shock ProteinsCell Line, TumorCell ProliferationApoptosisAntineoplastic Agents

Stichwörter der Autor:innen

GRP78TRIM3drug resistanceendoplasmic reticulum stress

Substanzen

HSPA5 protein, humanEndoplasmic Reticulum Chaperone BiPCisplatinTRIM3 protein, humanTripartite Motif ProteinsHeat-Shock ProteinsCarrier ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, PR China.
  • Traditional Chinese Medicine Hospital of Ninghai County, Ningbo, Zhejiang, PR China.

ORCID-Profile: Huiqing Ding

Zitieren

APA

Mao, M., You, T., Xu, K., & Ding, H. (2025). TRIM3 modulates cisplmatin-resistant of cervical squamous cell carcinoma via endoplasmic reticulum stress signaling in vitro. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2024-0154

Vancouver

Mao M, You T, Xu K, Ding H. TRIM3 modulates cisplmatin-resistant of cervical squamous cell carcinoma via endoplasmic reticulum stress signaling in vitro. Biochemistry and Cell Biology. 2025. doi:10.1139/bcb-2024-0154

BibTeX
@article{Mao2025,
  author = {Mao, Meiya and You, Tianzi and Xu, Kejun and Ding, Huiqing},
  title = {TRIM3 modulates cisplmatin-resistant of cervical squamous cell carcinoma via endoplasmic reticulum stress signaling in vitro},
  journal = {Biochemistry and Cell Biology},
  year = {2025},
  doi = {10.1139/bcb-2024-0154}
}
Kostenlos starten →